Logo

Zealand Pharma to Acquire Valeritas' Business and Retain its Employees

Share this

M&A

Zealand Pharma to Acquire Valeritas' Business and Retain its Employees

Shots:

  • Valeritas to sell all its business to Zealand- in an all-cash transaction of ~$23M. Zealand will continue Valeritas’ commercially-focused operations and retain nearly all its employees
  • For the smooth accomplishment of a transaction- Valeritas and its subsidiaries filed voluntary petitions for relief under Chapter 11 of the US bankruptcy code in the court. The transaction ponders the retention of total Valeritas’ workforce
  • Valeritas expects to obtain Debtor-in-Possession (DIP) financing to support the ongoing operation including the production & commercialization of V-Go. The V-Go wearable insulin delivery device is an all-in-one basal-bolus insulin delivery option for adult patients requiring insulin- eliminating the need for taking multiple daily shots

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Take Care of Your Diabetes


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions